These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 32110658)
1. Comprehensive review into the challenges of gastrointestinal tumors in the Gulf and Levant countries. Rare Tumors Gi Group ; Farhat F; Farsi AA; Mohieldin A; Bahrani BA; Sbaity E; Jaffar H; Kattan J; Rasul K; Saad K; Assi T; Morsi WE; Abood RA World J Clin Cases; 2020 Feb; 8(3):487-503. PubMed ID: 32110658 [TBL] [Abstract][Full Text] [Related]
2. Phase II Trial of Continuous Regorafenib Dosing in Patients with Gastrointestinal Stromal Tumors After Failure of Imatinib and Sunitinib. Kim JJ; Ryu MH; Yoo C; Beck MY; Ma JE; Kang YK Oncologist; 2019 Nov; 24(11):e1212-e1218. PubMed ID: 31036770 [TBL] [Abstract][Full Text] [Related]
3. The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines. Nishida T; Blay JY; Hirota S; Kitagawa Y; Kang YK Gastric Cancer; 2016 Jan; 19(1):3-14. PubMed ID: 26276366 [TBL] [Abstract][Full Text] [Related]
4. The GOLD ReGISTry: a Global, Prospective, Observational Registry Collecting Longitudinal Data on Patients with Advanced and Localised Gastrointestinal Stromal Tumours. Barrios CH; Blackstein ME; Blay JY; Casali PG; Chacon M; Gu J; Kang YK; Nishida T; Purkayastha D; Woodman RC; Reichardt P Eur J Cancer; 2015 Nov; 51(16):2423-33. PubMed ID: 26248685 [TBL] [Abstract][Full Text] [Related]
5. Current management of gastrointestinal stromal tumors--a comprehensive review. Lai EC; Lau SH; Lau WY Int J Surg; 2012; 10(7):334-40. PubMed ID: 22633986 [TBL] [Abstract][Full Text] [Related]
6. Advances and Challenges on Management of Gastrointestinal Stromal Tumors. Mei L; Du W; Idowu M; von Mehren M; Boikos SA Front Oncol; 2018; 8():135. PubMed ID: 29868467 [TBL] [Abstract][Full Text] [Related]
7. Asian consensus guidelines for gastrointestinal stromal tumor: what is the same and what is different from global guidelines. Nishida T Transl Gastroenterol Hepatol; 2018; 3():11. PubMed ID: 29552662 [TBL] [Abstract][Full Text] [Related]
8. Regorafenib: a novel multitargeted tyrosine kinase inhibitor for colorectal cancer and gastrointestinal stromal tumors. Crona DJ; Keisler MD; Walko CM Ann Pharmacother; 2013 Dec; 47(12):1685-96. PubMed ID: 24259629 [TBL] [Abstract][Full Text] [Related]
9. [Similarities and differences in diagnosis and treatment of gastrointestinal stromal tumors between China, Japan and Korea: from expert consensus to cooperation prospect]. Cao H; Wang M Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Sep; 22(9):812-819. PubMed ID: 31550818 [TBL] [Abstract][Full Text] [Related]
10. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours. Croom KF; Perry CM Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228 [TBL] [Abstract][Full Text] [Related]
11. Tyrosine kinase inhibitors in the treatment of unresectable or metastatic gastrointestinal stromal tumors. Nishida T; Doi T; Naito Y Expert Opin Pharmacother; 2014 Oct; 15(14):1979-89. PubMed ID: 24990162 [TBL] [Abstract][Full Text] [Related]
12. Current clinical strategy for imatinib-resistant gastrointestinal stromal tumors. Yamamoto M; Konno H Clin J Gastroenterol; 2009 Jun; 2(3):137-142. PubMed ID: 26192283 [TBL] [Abstract][Full Text] [Related]
13. The Role of Surgery in Metastatic Gastrointestinal Stromal Tumors. Keung EZ; Fairweather M; Raut CP Curr Treat Options Oncol; 2016 Feb; 17(2):8. PubMed ID: 26820287 [TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal stromal tumours (GISTs): French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO). Landi B; Blay JY; Bonvalot S; Brasseur M; Coindre JM; Emile JF; Hautefeuille V; Honore C; Lartigau E; Mantion G; Pracht M; Le Cesne A; Ducreux M; Bouche O; ; ; ; ; ; ; Dig Liver Dis; 2019 Sep; 51(9):1223-1231. PubMed ID: 31387778 [TBL] [Abstract][Full Text] [Related]
15. Differential properties of current tyrosine kinase inhibitors in gastrointestinal stromal tumors. Demetri GD Semin Oncol; 2011 Apr; 38 Suppl 1():S10-9. PubMed ID: 21419931 [TBL] [Abstract][Full Text] [Related]
16. Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation. Wilson J; Connock M; Song F; Yao G; Fry-Smith A; Raftery J; Peake D Health Technol Assess; 2005 Jul; 9(25):1-142. PubMed ID: 15985189 [TBL] [Abstract][Full Text] [Related]